Robert Kramer, retiring Emergent BioSolutions CEO
June 27, 2023 11:33 AM EDT
People
Manufacturing

Emer­gent BioSo­lu­tions CEO Robert Kramer an­nounces re­tire­ment

Tyler Patchen

News Reporter

Robert Kramer, the CEO of con­tract man­u­fac­tur­er Emer­gent BioSo­lu­tions, is re­tir­ing af­ter more than two decades, in­clud­ing lead­ing the com­pa­ny through a some­times-tur­bu­lent Covid-19 pan­dem­ic …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times